These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 4656677)

  • 21. Medical treatment of canine hyperadrenocorticoidism with o,p'-DDD.
    Lorenz MD; Scott DW; Pulley LT
    Cornell Vet; 1973 Oct; 63(4):646-65. PubMed ID: 4748884
    [No Abstract]   [Full Text] [Related]  

  • 22. [Effect of O,P-DDD on the islands of Langerhans and some indices of carbohydrate metabolism].
    Kosmach PI
    Vrach Delo; 1969 Jul; 7():85-8. PubMed ID: 4909062
    [No Abstract]   [Full Text] [Related]  

  • 23. [The effect of o,pi-DDD and its analogues on glucose-6-phosphate dehydrogenase of dog and guinea pig adrenals].
    Mikosha OS; Komisarenko VP
    Ukr Biokhim Zh; 1971; 43(3):311-4. PubMed ID: 5154455
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparative CYP-dependent binding of the adrenocortical toxicants 3-methylsulfonyl-DDE and o,p'-DDD in Y-1 adrenal cells.
    Hermansson V; Asp V; Bergman A; Bergström U; Brandt I
    Arch Toxicol; 2007 Nov; 81(11):793-801. PubMed ID: 17487473
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effects of o,p,-dichlorodiphenyldichloroethane (o,p'-DDD) on the development of the submaxillary gland in the rat].
    Lacassagne A; Hurst L; Nguyen Ba Giao
    C R Acad Hebd Seances Acad Sci D; 1968 Apr; 266(14):1532-4. PubMed ID: 4970675
    [No Abstract]   [Full Text] [Related]  

  • 26. [Restorative processes in the adrenal cortex of dogs after administration of O,P'-DDD].
    Komissarenko VP; Gordienko VM; Reznikov AG
    Probl Endokrinol (Mosk); 1972; 18(3):74-81. PubMed ID: 5029293
    [No Abstract]   [Full Text] [Related]  

  • 27. [Accumulation and elimination of o,p'-DDD in organs and tissues of guinea pigs and dogs].
    Korpachev VV
    Fiziol Zh; 1972; 18(5):585-90. PubMed ID: 4656676
    [No Abstract]   [Full Text] [Related]  

  • 28. [Selective atrophy of the adrenal cortex with dichlorodiphenylchloroethane I-131 (DDD I-131)].
    Skromne-Kadlubik G; Férez A; Celis C
    Arch Inst Cardiol Mex; 1974; 44(6):869-73. PubMed ID: 4441159
    [No Abstract]   [Full Text] [Related]  

  • 29. Fine structural and biochemical effects of aminoglutethimide and o,p'-DDD on rat adrenocortical carcinoma 494 and adrenals.
    Moore RN; Penney DP; Averill KT
    Anat Rec; 1980 Sep; 198(1):113-24. PubMed ID: 7457928
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mitotane increases the radiotherapy inhibitory effect and induces G2-arrest in combined treatment on both H295R and SW13 adrenocortical cell lines.
    Cerquetti L; Bucci B; Marchese R; Misiti S; De Paula U; Miceli R; Muleti A; Amendola D; Piergrossi P; Brunetti E; Toscano V; Stigliano A
    Endocr Relat Cancer; 2008 Jun; 15(2):623-34. PubMed ID: 18509009
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The association between organochlorine and thyroid hormone levels in cord serum: a study from northern Thailand.
    Asawasinsopon R; Prapamontol T; Prakobvitayakit O; Vaneesorn Y; Mangklabruks A; Hock B
    Environ Int; 2006 May; 32(4):554-9. PubMed ID: 16492389
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Method of determination of p,p'-DDE and p,p'-DDD-gamma-HCH and p,p'-DDD- p,p'-methoxychlor (p,p'-DMDT) in rape seed, oil and milk].
    Parys J
    Rocz Panstw Zakl Hig; 1971; 22(4):441-8. PubMed ID: 5171836
    [No Abstract]   [Full Text] [Related]  

  • 33. Pharmacokinetics of the adrenocorticolytic compounds 3-methylsulphonyl-DDE and o,p'-DDD (mitotane) in Minipigs.
    Hermansson V; Cantillana T; Hovander L; Bergman A; Ljungvall K; Magnusson U; Törneke K; Brandt I
    Cancer Chemother Pharmacol; 2008 Feb; 61(2):267-74. PubMed ID: 17431626
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effect of chloditan on the changes of activity of glutathione transferase, glutathione reductase and glutathione content in the adrenal glands and liver in rats].
    Zorich PA; Tronko ND; Mikosha AS
    Fiziol Zh (1994); 1994; 40(1):86-90. PubMed ID: 7713231
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interindividual differences in o,p'-DDD enantiomer kinetics examined in Göttingen minipigs.
    Cantillana T; Lindström V; Eriksson L; Brandt I; Bergman A
    Chemosphere; 2009 Jun; 76(2):167-72. PubMed ID: 19394667
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of o,p'-DDD and metyrapone (SU-4885) on development of renal hypertension in rats.
    Fregly MJ
    Toxicol Appl Pharmacol; 1968 May; 12(3):548-59. PubMed ID: 5675482
    [No Abstract]   [Full Text] [Related]  

  • 37. Cardiovascular effects of o,p'-DDD.
    Cueto C
    IMS Ind Med Surg; 1968 Jul; 37(7):520. PubMed ID: 5243492
    [No Abstract]   [Full Text] [Related]  

  • 38. [Properties of adrenocortical isocitrate dehydrogenase].
    Mikosha AS; Monissarenko VP; Bychkovskaia LA
    Vopr Med Khim; 1981; 27(6):736-9. PubMed ID: 7336646
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effect of o,p-DDD on the secretion of 11- and 17-hydroxycorticosteroids in dogs during stress].
    Reznikov AG; Kravtsova EL
    Patol Fiziol Eksp Ter; 1970; 14(4):38-40. PubMed ID: 5508578
    [No Abstract]   [Full Text] [Related]  

  • 40. Use of the urine cortisol-to-creatinine ratio for monitoring dogs with pituitary-dependent hyperadrenocorticism during induction treatment with mitotane (o,p'-DDD).
    Randolph JF; Toomey J; Center SA; Scarlett JM; Reimers T; Graham P; Nachreiner RF
    Am J Vet Res; 1998 Mar; 59(3):258-61. PubMed ID: 9522940
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.